Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Menopause Health Center

Font Size

FDA Announces New Drug Approval for Menopause

Enjuvia: Synthetic, Plant-Derived Estrogen Helps Hot Flashes
WebMD Health News

May 11, 2004 -- The FDA has approved Enjuvia for treatment of moderate to severe symptoms related to menopause, the drug's manufacturer reports.

Enjuvia is a plant-derived estrogen product. It was developed by Endeavor Pharmaceuticals, which in December 2003 sold the product to Barr Pharmaceuticals Inc. Barr also makes another plant-derived estrogen product, Cenestin, through its wholly owned subsidiary Duramed Pharmaceuticals. Cenestin received FDA approval in 1999.

"We believe that Enjuvia, which is a patented synthetic conjugated estrogens product, will offer a new generation of hormonal products to American women electing to use hormone therapy," Barr CEO Bruce L. Downey said in a news release.

Clinical studies show that Enjuvia can reduce the frequency and severity of hot flashes in women going through menopause. Doses as low as 0.3 milligram were reported to be effective. However, the current FDA approval applies only to Enjuvia at doses of 0.625 milligrams and 1.25 milligrams. An application for FDA approval of lower-dose Enjuvia tablets is pending.

Because some studies link estrogen therapy to increased risk of endometrial cancer in postmenopausal women with uteruses, doctors usually prescribed it in combination with progestin hormones. Because of other potential risks of estrogen therapy, current recommendations advise using the treatment at as low a dose as possible and for as short a time as possible.

Today on WebMD

woman walking outdoors
How to handle headaches, night sweats, and more.
mature woman holding fan in face
Symptoms and treatments.
woman hiding face behind hands
11 ways to keep skin bright and healthy.
Is it menopause or something else?
senior couple
mature woman shopping for produce
Alcohol Disrupting Your Sleep
mature couple on boat
mature woman tugging on her loose skin
senior woman wearing green hat
estrogen gene

WebMD Special Sections